MedPath

Study on contrast-induced nephropathy preventive effect of remote preconditioning in elective PCI patients

Not Applicable
Conditions
CKD inhospital patients(eGFR&lt
60ml/min/m2) undergoing elective PCI
Registration Number
JPRN-UMIN000010751
Lead Sponsor
Osaka General Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
180
Inclusion Criteria

Not provided

Exclusion Criteria

*Patients receiving dialysis *Patients having any cancer *Patients who have difficulty with pessing upper arm in mentally or physically *Patients who don't give the consent of the participants to the test *Patients whom the principal investigator judged to be inappropriate as a subject

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
*Change of creatinine level in acute and chronic phases before and after of the CI treatment *Change of the urinary L-FABP level(CIN or not)
Secondary Outcome Measures
NameTimeMethod
MACE(death,cardiac infarction,target vessel retreatment: Having RIPC or not, Are there difference having CIN or not?, microglobulin in the urine, erythropoietin in the blood : Mechanism of CIN onset, Guess the mechanism of the effect of RIPC)
© Copyright 2025. All Rights Reserved by MedPath